[go: up one dir, main page]

AR040684A1 - Forma de dosificacion solida recubierta y metodo de preparacion de la misma - Google Patents

Forma de dosificacion solida recubierta y metodo de preparacion de la misma

Info

Publication number
AR040684A1
AR040684A1 AR20030102669A ARP030102669A AR040684A1 AR 040684 A1 AR040684 A1 AR 040684A1 AR 20030102669 A AR20030102669 A AR 20030102669A AR P030102669 A ARP030102669 A AR P030102669A AR 040684 A1 AR040684 A1 AR 040684A1
Authority
AR
Argentina
Prior art keywords
solid dosage
dosage form
coating solution
coated
same preparation
Prior art date
Application number
AR20030102669A
Other languages
English (en)
Inventor
John Heimlich
Robert Noack
David Grant
Ernest Lee
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of AR040684A1 publication Critical patent/AR040684A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Método para preparar una forma de dosificación sólida recubierta que comprende los pasos de (a) aplicar una solución de recubrimiento a una forma de dosificación sólida, (b) curar la forma de dosificación sólida recubierta en el paso (a) y (c) repetir el paso (a). Reivindicación 1: Un método para preparar una forma de dosificación sólida recubierta que comprende los pasos de: (a) aplicar una primera capa de una solución de recubrimiento a una forma de dosificación sólida, comprendiendo la solución de recubrimiento un polímero insoluble en agua y un formador de poros soluble en agua, teniendo la forma de dosificación sólida un agente activo dispersado en la misma; (b) curar la forma de dosificación sólida recubierta en el paso (a); y (c) aplicar una segunda capa de la solución de recubrimiento a la fórmula de dosificación sólida.
AR20030102669A 2002-07-25 2003-07-24 Forma de dosificacion solida recubierta y metodo de preparacion de la misma AR040684A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39837002P 2002-07-25 2002-07-25

Publications (1)

Publication Number Publication Date
AR040684A1 true AR040684A1 (es) 2005-04-13

Family

ID=31188387

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20030102669A AR040684A1 (es) 2002-07-25 2003-07-24 Forma de dosificacion solida recubierta y metodo de preparacion de la misma

Country Status (10)

Country Link
US (1) US20040137156A1 (es)
EP (1) EP1526843A1 (es)
JP (1) JP2005538105A (es)
AR (1) AR040684A1 (es)
AU (1) AU2003261223A1 (es)
BR (1) BR0312876A (es)
CA (1) CA2488860A1 (es)
MX (1) MXPA05001003A (es)
TW (1) TW200413033A (es)
WO (1) WO2004010982A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
MY142204A (en) 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
US20060118003A1 (en) * 2002-12-17 2006-06-08 Yukoh Sakata Light-blocking agent and film-forming composition
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2011244902B2 (en) * 2004-08-13 2012-09-27 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
KR20070050081A (ko) * 2004-08-13 2007-05-14 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도
RS52057B2 (sr) * 2004-08-13 2018-03-30 Boehringer Ingelheim Int Formulacija tablete sa produženim oslobađanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
ES2409347T3 (es) 2004-10-21 2013-06-26 Aptalis Pharmatech, Inc. Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
WO2006046256A1 (en) * 2004-10-27 2006-05-04 Alembic Limited Extended release formulation of pramipexole dihydrochloride
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2006127879A1 (en) * 2005-05-26 2006-11-30 Duramed Pharmaceuticals, Inc. Flexible solid dosage forms and methods of making and using the same
EP1901721A1 (en) * 2005-06-23 2008-03-26 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
WO2007090882A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Pharmaceutical extended release compositions comprising pramipexole
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP5167345B2 (ja) * 2007-05-07 2013-03-21 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤を加速放出する腸溶コーティングを含む固体剤形
WO2009019599A2 (en) 2007-08-08 2009-02-12 Themis Laboratories Private Limited Extended release compositions comprising tolterodine
US20090194533A1 (en) * 2008-02-04 2009-08-06 Lizerbram Eric K Closure with additive reservoir
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
UY33173A (es) * 2010-01-08 2011-07-29 Eurand Inc
KR101307334B1 (ko) * 2010-07-02 2013-09-12 주식회사 바이오파마티스 프라미펙솔 또는 이의 약학적으로 허용되는 염을 포함하는 안정성이 개선된 서방형 약학 조성물
CN102018658B (zh) * 2010-07-16 2014-03-12 钟术光 一种控释制剂及其制备方法
WO2013034173A1 (en) 2011-09-06 2013-03-14 Synthon Bv Pramipexole extended release tablets
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
CN104606162B (zh) * 2015-01-07 2017-03-29 海南康虹医药科技开发有限公司 一种盐酸普拉克索缓释制剂及其制备方法
JP6366547B2 (ja) * 2015-08-03 2018-08-01 大原薬品工業株式会社 光安定性が向上した、プラミペキソール製剤包装体
CN109939658B (zh) * 2019-04-17 2022-11-01 邱俊琅 一种萃取涂层、固相微萃取探针及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US612933A (en) * 1898-10-25 J s rogees
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6432322B1 (en) * 2000-02-02 2002-08-13 Engelhard Corporation Massive bodies for producing highly converted solutions of chlorine dioxde
AU2002357366A1 (en) * 2001-12-20 2003-07-09 Pharmacia Corporation Multiple-pulse extended release formulations of clindamycin

Also Published As

Publication number Publication date
BR0312876A (pt) 2005-06-28
EP1526843A1 (en) 2005-05-04
WO2004010982A1 (en) 2004-02-05
JP2005538105A (ja) 2005-12-15
MXPA05001003A (es) 2005-05-16
TW200413033A (en) 2004-08-01
CA2488860A1 (en) 2004-02-05
AU2003261223A1 (en) 2004-02-16
US20040137156A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
AR040684A1 (es) Forma de dosificacion solida recubierta y metodo de preparacion de la misma
MX9305438A (es) Perlas que tienen un nucleo revestido con un agente antimicotico y un polimero.
DE69914320D1 (de) Verfahren zur herstellung einer mit bändern versehenen dosisform zur verlängerten freisetzung eines wirkstoffs
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
MEP23508A (en) Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
AR018637A1 (es) Un fertilizante de liberacion controlada y un procedimiento para su preparacion
AR031611A1 (es) Sistema de enduido de cemento
DE69915346D1 (de) Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
UY26527A1 (es) Sistema de suministro de droga por difusión/bombeo osmótico combinados
JP2004535227A5 (es)
PT1079813E (pt) Dispositivo transportador farmaceutico adequado para entrega de compostos farmaceuticos as superficies mucosas
AR048017A1 (es) Composicion y metodo para aumentar la biodisponibilidad
ES2157731B1 (es) Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
AR048050A1 (es) Formas de administracion masticables, no comprimidas, dosificadas individualmente
ITMI20041492A1 (it) Nuovo dispositivo per il rilascio di principi attivi
DK1345595T3 (da) Ionstyrke-uafhængig farmaceutisk formulering med depotfrigivelse
AR047986A1 (es) Composiciones de pelicula
AR065522A1 (es) Pelicula de monocapa de desintegracion rapida para administracion bucal de sustancias activas
PE20000224A1 (es) Formulacion medicamentosa con liberacion controlada de sustancia activa
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
DE60125750D1 (de) Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir
ATE395048T1 (de) Betahistinezubereitungen mit kontrollierter freisetzung
CL2004000884A1 (es) Composicion farmaceutica en forma de hidrogel que contiene un diester de acido carbonico, un alquilalcohol c2-c4, por lo menos una sustancia activa y una matriz de polimero; uso en el tratamiento de carencias esteroidales.
BG104757A (en) Pellets having a core coated with a lipid lowering agent and a polymer
CR8973A (es) Composicion farmaceutica en forma de una forma de dosificacion solida soluble en agua

Legal Events

Date Code Title Description
FA Abandonment or withdrawal